Consolidated statement of comprehensive income

(Rm)	Notes	Six months ended 31 December 2014 (Reviewed)	Six months ended 31 December 2013 (Reviewed)	Year ended 30 June 2014 (Audited)
Revenue		15 903	16 502	29 028
Cost of sales	10	(14 384)	(14 742)	(25 786)
Gross profit		1 519	1 760	3 242
Other operating income	11	375	59	239
Other operating expenses	11	(1 113)	(75)	(2 809)
Royalty expense		(319)	(407)	(693)
Profit/(loss) from operations		462	1 337	(21)
Finance income		81	163	318
Finance cost		(174)	(247)	(496)
Net foreign exchange transaction gains/(losses)		(219)	(19)	(101)
Other income		149	104	203
Other expenses		(87)	(109)	(253)
Share of profit of equity-accounted entities		231	130	365
Profit before tax		443	1 359	15
Income tax expense		(160)	(437)	(144)
Profit/(loss) for the period		283	922	(129)
Other comprehensive income, comprising items that may subsequently be reclassified to profit or loss:
Available-for-sale financial assets		(9)	1	(56)
Deferred tax thereon		(2)	—	—
Share of other comprehensive income of equity-accounted entities		153	—	120
Deferred tax thereon		(15)	—	(12)
Exchange differences on translating foreign operations		932	668	711
Deferred tax thereon		(121)	(170)	(93)
Other comprehensive income, comprising items that will not be subsequently reclassified to profit or loss:
Actuarial loss on post-employment medical benefit		—	—	(1)
Deferred tax thereon		—	—	—
Total comprehensive income		1 221	1 421	540
Profit/(loss) attributable to:
Owners of the Company		249	879	8
Non-controlling interest		34	43	(137)
		283	922	(129)
Total comprehensive income/(loss) attributable to:
Owners of the Company		1 065	1 304	569
Non-controlling interest		156	117	(29)
		1 221	1 421	540
Earnings per share (cents per share):
Basic		41	145	1
Diluted		41	145	1

For headline earnings per share and dividend per share refer notes 12 and 13.

The notes on pages 15 to 26 are an integral part of these condensed interim financial statements.